Dr. David “Doc” Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree from Northwestern University’s Kellogg School of Management. There, he graduated on the Dean’s List with a double major in finance and international business.
Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the “Goldman Sachs of Japan”).
That’s when Doc’s career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University’s postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.
Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.
However, frustrated by Big Medicine’s many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc’s Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.
Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research’s parent company.

Products & Newsletters
Retirement Millionaire
Summary
The best “how to” guide to set yourself up for the richest retirement possible. Retirement Millionaire is a monthly advisory that shows readers how to live a millionaire lifestyle on less money than you’d imagine possible.
Editor & Analysts
Dr. David “Doc” Eifrig, Editor
Matt Weinschenk, Analyst
Jeff Havenstein, Analyst
Laura Bente, Analyst
Retirement Trader
Summary
Retirement Trader is a twice-monthly trading advisory where editor Dr. David Eifrig, Jr. shows you a safe way to double or triple the gains in your retirement account, with much less risk.
Editor & Analysts
Dr. David “Doc” Eifrig, Editor
Matt Weinschenk, Analyst
Jeff Havenstein, Analyst
Laura Bente, Analyst
Income Intelligence
Summary
Income Intelligence is an income advisory that shows readers how to analyze the income markets to maximize their income and total returns. It covers stocks, bonds, and alternative investments.
Editor & Analysts
Dr. David “Doc” Eifrig, Editor
Matt Weinschenk, Analyst
Prosperity Investor
Summary
This newsletter led by Dr. David Eifrig and John Engel explores the huge opportunity as the health care sector and technology take off over the coming years… Through investing, becoming better health care consumers, and improving our overall health…
Editor & Analysts
Dr. David “Doc” Eifrig, Editor
John Engel, Analyst
Jeff Havenstein, Analyst
Doc’s Latest Content
Two Ways to Keep Joint Pain at Bay
When the cold weather hits, your joints feel it...
Read the articleWhat to Expect for Stocks in 2026
We're feeling optimistic about the stock market this year...
Read the article